Public Release: 

Primary prevention could reduce heart disease among type 2 diabetes patients

American College of Cardiology

IMAGE

IMAGE: In a Journal of the American College of Cardiology state of the art review published today, researchers from the division of cardiology and the Center for the Prevention of Cardiovascular... view more 

Credit: Newman, J.D. et al. J Am Coll Cardiol. 2017;70(7):883-93.

WASHINGTON (Aug. 7, 2017) -- In a Journal of the American College of Cardiology state of the art review published today, researchers from the division of cardiology and the Center for the Prevention of Cardiovascular Disease at the New York University Medical Center in New York City, examine evidence and guidelines for the prevention of heart disease in Type 2 Diabetes patients.

Type 2 Diabetes Mellitus is one of the leading risk factors for heart disease and the most common cause of death in patients with Type 2 Diabetes. According to the Centers for Disease Control and Prevention, approximately 1 in 3 U.S. individuals may have Type 2 Diabetes by 2050. These patients will comprise an increasingly large portion of the heart disease population. However, less than 50 percent of U.S. adults with Type 2 Diabetes meet recommended guidelines for heart disease prevention.

The researchers wrote, "cardiovascular risk reduction is critically important for the care of patients with diabetes, with or without known CVD and CV risk factors." They state the use of proven medical therapies, such as statins, aspirin and glucose lowering therapies, should be considered along with lifestyle management including exercise, nutrition and weight management, for all Type 2 Diabetes patients. This has the potential to significantly reduce the burden of heart disease among these patients.

###

The American College of Cardiology is the professional home for the entire cardiovascular care team. The mission of the College and its more than 52,000 members is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, offers cardiovascular accreditation to hospitals and institutions, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more, visit acc.org.

The Journal of the American College of Cardiology ranks among the top cardiovascular journals in the world for its scientific impact. JACC is the flagship for a family of journals--JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging, JACC: Heart Failure, JACC: Clinical Electrophysiology and JACC: Basic to Translational Science--that prides themselves in publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at JACC.org.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.